NCT00324454View on ClinicalTrials.gov

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

June 30, 2008

Conditions
Motor Neuron DiseaseAmyotrophic Lateral SclerosisPrimary Lateral SclerosisProgressive Muscular Atrophy
Interventions
BIOLOGICAL

Levetiracetam

Levetiracetam 1500 mg BID

Trial Locations (1)

27705

Duke University ALS Clinic - 932 Morreene Road, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Duke University

OTHER